Literature DB >> 25757447

Factors Associated with the Quality of Transient Elastography.

Eva Juárez-Hernández1, Martha Helena Uribe-Ramos, Martha Helena Ramos-Ostos, Angélica Yanine López-Ramírez, Sofía Ornelas-Arroyo, Juan Luis Romero-Flores, Nahúm Méndez-Sánchez, Misael Uribe, Norberto C Chávez-Tapia.   

Abstract

BACKGROUND: Transient elastography is a noninvasive method for the evaluation of fibrosis in chronic liver disease. However, its reliability is variable, and the factors associated with its accuracy have not been identified completely. AIMS: To identify the factors associated with the reliability of transient elastography.
METHODS: A total of 2033 transient elastography measurements were taken from March 2009 to October 2013. Reliability was determined according to the interquartile range/median (IQR/M < 0.30 = reliable; IQR/M < 0.10 = very reliable). Other indicators such as the percentage of successful measurements (>60 %), time of performance, and probe size were recorded. Potential factors that could affect the reliability of the procedure were analyzed using multivariate logistic regression.
RESULTS: Slightly less than 5 % of the measurements were unsuccessful, and 83 % of the successful measurements were found to be reliable. Factors associated with an unsuccessful measurement were female gender, incorrect probe size, and the presence of HCV infection. Unreliable measurements were associated with use of the procedure as part of a clinical study and success rate. Very reliable evaluations were associated with >10 measurements, the presence of chronic hepatic disease, and a success rate of >60 %.
CONCLUSIONS: The operator and clinical and anthropometric characteristics are factors that influence the success and reliability of transient elastography. Improvements in the quality of the procedure are needed to provide better diagnostic accuracy in clinical practice.

Entities:  

Mesh:

Year:  2015        PMID: 25757447     DOI: 10.1007/s10620-015-3611-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.

Authors:  Philipp Schwabl; Simona Bota; Petra Salzl; Mattias Mandorfer; Berit A Payer; Arnulf Ferlitsch; Judith Stift; Friedrich Wrba; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger
Journal:  Liver Int       Date:  2014-07-09       Impact factor: 5.828

2.  Interobserver discrepancy in liver fibrosis using transient elastography.

Authors:  B Roca; E Resino; V Torres; E Herrero; M Penades
Journal:  J Viral Hepat       Date:  2012-03-27       Impact factor: 3.728

3.  Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.

Authors:  Monica Lupsor; Radu Badea; Horia Stefanescu; Mircea Grigorescu; Alexandru Serban; Corina Radu; Dana Crişan; Zeno Sparchez; Sorana Iancu; Anca Maniu
Journal:  J Gastrointestin Liver Dis       Date:  2010-03       Impact factor: 2.008

4.  [Comparison of the M and XL FibroScan(®) probes to estimate liver stiffness by transient elastography].

Authors:  José Ignacio Herrero; Mercedes Iñarrairaegui; Delia D'Avola; Bruno Sangro; Jesús Prieto; Jorge Quiroga
Journal:  Gastroenterol Hepatol       Date:  2014-01-11       Impact factor: 2.102

Review 5.  Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis.

Authors:  Simona Bota; Harald Herkner; Ioan Sporea; Petra Salzl; Roxana Sirli; Adriana M Neghina; Markus Peck-Radosavljevic
Journal:  Liver Int       Date:  2013-07-16       Impact factor: 5.828

6.  Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.

Authors:  Robert P Myers; Gilles Pomier-Layrargues; Richard Kirsch; Aaron Pollett; Melanie Beaton; Mark Levstik; Andres Duarte-Rojo; David Wong; Pam Crotty; Magdy Elkashab
Journal:  J Hepatol       Date:  2011-10-23       Impact factor: 25.083

7.  Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy.

Authors:  Robert P Myers; Pam Crotty; Gilles Pomier-Layrargues; Mang Ma; Stefan J Urbanski; Magdy Elkashab
Journal:  Liver Int       Date:  2010-08-30       Impact factor: 5.828

8.  Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases.

Authors:  Fabio Nascimbeni; Pascal Lebray; Larysa Fedchuk; Claudia P Oliveira; Mario Reis Alvares-da-Silva; Anne Varault; Patrick Ingiliz; Yen Ngo; Mercedes de Torres; Mona Munteanu; Thierry Poynard; Vlad Ratziu
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-30       Impact factor: 11.382

9.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

10.  Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice.

Authors:  M J Armstrong; C Corbett; J Hodson; N Marwah; R Parker; D D Houlihan; I A Rowe; J M Hazlehurst; R Brown; S G Hübscher; D Mutimer
Journal:  Postgrad Med J       Date:  2013-08-07       Impact factor: 2.401

View more
  8 in total

1.  The usefulness of transient elastography in patients with autoimmune hepatitis-when can we use it?

Authors:  Nahum Méndez-Sánchez; Xingshun Qi
Journal:  Ann Transl Med       Date:  2018-08

2.  Noninvasive Measures of Liver Fibrosis and Severity of Liver Disease.

Authors:  Catherine Lucero; Robert S Brown
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-01

Review 3.  Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ma Ai Thanda Han; Rola Saouaf; Walid Ayoub; Tsuyoshi Todo; Edward Mena; Mazen Noureddin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-03-09       Impact factor: 5.045

4.  Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease.

Authors:  Zohair Ahmed; Jinma Ren; Adam Gonzalez; Umair Ahmed; Saqib Walayat; Daniel K Martin; Harsha Moole; Sherri Yong; Sean Koppe; Sonu Dhillon
Journal:  Hepat Med       Date:  2018-10-24

5.  Liver function tests in identifying patients with liver disease.

Authors:  Zohair Ahmed; Umair Ahmed; Saqib Walayat; Jinma Ren; Daniel K Martin; Harsha Moole; Sean Koppe; Sherri Yong; Sonu Dhillon
Journal:  Clin Exp Gastroenterol       Date:  2018-08-23

6.  Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.

Authors:  Taisa Grotta Ragazzo; Denise Paranagua-Vezozzo; Fabiana Roberto Lima; Daniel Ferraz de Campos Mazo; Mário Guimarães Pessoa; Claudia Pinto Oliveira; Venancio Avancini Ferreira Alves; Flair José Carrilho
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365

Review 7.  The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider.

Authors:  Nicolás Salva-Pastor; Norberto C Chávez-Tapia; Misael Uribe; Natalia Nuño-Lámbarri
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

Review 8.  Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome.

Authors:  Ma Ai Thanda Han
Journal:  Life (Basel)       Date:  2020-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.